ArticleCureus2026
Replacing Routine Oxytocin Infusion With Single-Dose Carbetocin at Elective Caesarean Section: A Service Improvement Evaluation of Postpartum Haemorrhage Outcomes.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Routine postoperative oxytocin infusion after elective caesarean section can require prolonged intravenous administration, continued monitoring, and additional recovery-area resources. Single-dose carbetocin offers a simplified prophylactic uterotonic regimen, but local evaluation is important when implementing a change in practice. Methods This was a single-centre service improvement evaluation using anonymised aggregate data from women undergoing elective lower-segment caesarean section across two consecutive time periods. The oxytocin cohort included 392 elective caesarean sections performed between 1 August 2022 and 30 September 2023, during which routine prophylaxis consisted of oxytocin according to local practice, typically including postoperative infusion. The carbetocin cohort included 446 elective caesarean sections performed between 1 October 2023 and 31 December 2024, following implementation of single-dose intravenous carbetocin as routine prophylaxis. The primary clinical outcome was significant postpartum haemorrhage, defined as estimated blood loss greater than 1.5 L. The secondary clinical outcome was major postpartum haemorrhage, defined as estimated blood loss greater than 2 L. The service outcome was avoidance of routine postoperative uterotonic infusion. Results A total of 838 elective caesarean sections were included. Significant postpartum haemorrhage occurred in 10 of 392 cases in the oxytocin cohort and 12 of 446 cases in the carbetocin cohort, corresponding to rates of 2.55% and 2.69%, respectively. Major postpartum haemorrhage occurred in 2 of 392 cases in the oxytocin cohort and 4 of 446 cases in the carbetocin cohort, corresponding to rates of 0.51% and 0.90%, respectively. Following implementation of carbetocin, routine postoperative uterotonic infusion was no longer required as part of standard prophylaxis. Conclusion In this service improvement evaluation, replacing routine oxytocin infusion with single-dose carbetocin at elective caesarean section was associated with comparable rates of significant and major postpartum haemorrhage while simplifying postoperative uterotonic administration. The findings support the local safety of this practice change, although interpretation is limited by the retrospective aggregate design and absence of patient-level risk adjustment or additional morbidity outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.